GPR183 and autoimmune disease: Our data provide insight into mechanisms by which EBI2 deficiency leads to dysregulated type I IFN production, a key driver of many autoimmune diseases, and reveals the EBI2/7α,25-OHC axis as a potential novel pathway in autoimmune disease pathogenesis.α.